Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease
Authors:
- Stephen H. BuckSBStephen H. Buck
- Thomas F. BurksTBThomas F. Burks
- Marvin R. BrownMBMarvin R. Brown
- Henry I. YamamuraHYHenry I. Yamamura
- 1 March 1981
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 209 (2) , 464-469
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Peptidergic neuronesNature, 1980
- Chemical Pathology of Huntington's DiseaseAnnual Review of Pharmacology and Toxicology, 1980
- Identification of authentic substance P in striatonigral and amygdaloid nuclei using combined high performance liquid chromatography and radioimmunoassayBrain Research, 1979
- Topographic projections of substance P and GABA pathways in the striato- and pallido-nigral system: A biochemical and immunohistochemical studyBrain Research, 1978
- Human brain substance P: distribution in controls and Huntington's choreaJournal of Neurochemistry, 1978
- On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigraBrain Research, 1977
- Projections of substance P containing neurons from neostriatum to substantia nigraBrain Research, 1977
- Regional distribution of substance P in the brain of the ratBrain Research, 1976
- Post morten changes and regional distribution of substance P in the rat and mouse nervous systemBrain Research, 1976
- Stimulation of adenylate cyclase activity in different areas of human brain by substance PNeuropharmacology, 1975